How to Read a Peptide Certificate of Analysis (COA)
Learn to decode every section of a peptide COA to verify identity, purity, and content. Essential guide for quality control in peptide research.
A Certificate of Analysis is the most important document in the peptide supply chain. It is the difference between a verified research compound and an unlabeled white powder. And yet, most people who buy peptides either never look at the COA, glance at the purity number and move on, or have no idea what they are actually reading.
This matters more than most people realize. A peptide could show 99% purity on HPLC and still be the wrong compound entirely. A vial labeled as 5 mg could contain only 3.5 mg of actual peptide. A COA could be fabricated, recycled from a different batch, or generated by the same company selling you the product with zero independent verification. If you are putting research compounds into your body, you need to understand what you are looking at.
This guide will walk you through every section of a COA, explain what each test actually measures, show you what good data looks like versus bad data, and give you a practical checklist for evaluating any peptide supplier's documentation.
"The number of times I have seen someone spend $400 on peptides and never once look at the COA is staggering. It is like buying a car without checking if the engine is actually in it. The COA is your only protection in an unregulated market. Learn to read it."
What Is a COA, and Why Does It Exist?
A Certificate of Analysis is a batch-specific laboratory report documenting the analytical testing performed on a peptide after synthesis. It answers three fundamental questions:
1. Identity
Is this actually the peptide it claims to be? Confirmed by Mass Spectrometry (MS).
2. Purity
What percentage of the sample is the target peptide vs. impurities? Confirmed by HPLC.
3. Content
How much actual peptide is in the vial versus water, salts, and counter-ions? Confirmed by amino acid analysis, Karl Fischer titration, or elemental analysis.
For pharmaceutical-grade (cGMP) peptides, a COA is extensive and legally required. For research-use-only (RUO) peptides, which is what most people in the peptide community encounter, the COA is less comprehensive but no less critical. Because RUO peptides are not regulated like pharmaceuticals, the COA is often your only quality assurance tool. The burden of verification falls entirely on you.
Anatomy of a COA: Section by Section
Let's walk through a COA as you would encounter it in the real world, section by section, starting from the top.
The Three Tests That Matter Most
1. Mass Spectrometry (MS): Is This the Right Peptide?
Mass spectrometry is the only reliable way to confirm that the peptide in the vial is actually the peptide on the label. HPLC cannot do this. A peptide missing one amino acid, or with a substitution error, can look perfectly pure on HPLC while being fundamentally the wrong compound.
MS works by measuring the molecular weight of the peptide with extreme precision. The COA will show two numbers: a theoretical mass (calculated from the amino acid sequence) and an observed mass (measured by the instrument). These should match within a tight tolerance, typically within 0.5 to 1.0 Dalton for singly charged ions.
Common MS findings that are normal and do not indicate a problem include sodium adducts (+22 Da from Na+), potassium adducts (+38 Da from K+), and multi-charge state peaks (where the peptide carries 2+ or 3+ charges, showing at half or one-third the expected mass). These are standard ionization artifacts.
A significant deviation from the theoretical mass, particularly one that corresponds to the mass of a single amino acid (roughly 57-186 Da depending on the residue), strongly suggests a deletion, truncation, or substitution error during synthesis.
HPLC cannot confirm sequence identity. A peptide with a single amino acid deletion can appear 99% pure on HPLC while being a fundamentally different molecule. Mass spectrometry is the only test that confirms you have the right compound. If a COA does not include MS data, it is incomplete.
2. HPLC Purity: How Clean Is It?
High-Performance Liquid Chromatography (HPLC) is the standard method for measuring peptide purity. It separates the target peptide from impurities based on their chemical properties (specifically, how they interact with a chromatographic column). The result is expressed as a percentage: the area under the main peak divided by the total area of all peaks.
A high-quality peptide will produce a chromatogram with a single dominant peak and minimal secondary peaks. The purity percentage reflects how much of the sample is your target compound. For most research applications, 95% or higher is acceptable. For sensitive work, aim for 98% or above.
One important nuance: high-purity peptides often display a single very sharp "spike" on the chromatogram. This is normal and reflects auto-scaling by the software, not an abnormality. The peak looks tall and narrow because there is so little impurity to provide a visual reference.
3. Net Peptide Content: The Number Most People Miss
This is the most misunderstood metric in peptide quality control, and getting it wrong directly affects your dosing accuracy.
Purity and content are not the same thing. HPLC purity tells you how much of the peptide-related material is the correct target peptide versus other peptide impurities. Net peptide content tells you how much of the total weight in the vial is actually peptide versus everything else: water, salts, and counter-ions (typically trifluoroacetic acid/TFA from the synthesis process).
The Math You Need to Do
A peptide can be 99% pure and only 75% net peptide content. That means if you have a "5 mg" vial:
5 mg total weight x 75% net content = 3.75 mg actual peptide
If you dissolve the entire vial assuming all 5 mg is active peptide, your molar concentration will be off by 25%. For quantitative research or precise dosing, this matters enormously. Always check net peptide content and adjust accordingly.
Typical net peptide content ranges from 60-90% for TFA salt forms, depending on the peptide's size and composition.
Other Tests You May See on a COA
| Test | What It Measures | Why It Matters | Standard for RUO? |
|---|---|---|---|
| Amino Acid Analysis (AAA) | Breaks peptide into individual amino acids and quantifies each | Confirms correct composition and ratios | Premium/custom only |
| Water Content (Karl Fischer) | Moisture in the lyophilized powder | High moisture accelerates degradation | GMP; sometimes RUO |
| Counter-ion Content | TFA or acetate salt percentage | Affects net content and dosing calculations | GMP; rarely RUO |
| Residual Solvents | Leftover chemicals from synthesis | Safety concern at high levels | GMP; rarely RUO |
| Endotoxin (LAL) | Bacterial endotoxin contamination | Critical for injectable peptides | Not standard for RUO |
| Sterility Testing | Presence of viable microorganisms | Critical for injectable use | Not standard for RUO |
| Bioburden | Total microbial count before sterilization | Indicates manufacturing cleanliness | GMP only |
"The difference between a research-grade COA and a cGMP COA is significant. A research COA typically gives you HPLC and MS. A pharmaceutical COA adds amino acid analysis, water content, counter-ion content, residual solvents, endotoxin, bioburden, sterility, mass balance, and specified impurity profiling. If a vendor claims 'pharmaceutical grade' but only provides HPLC and MS data, that claim does not hold up."
Third-Party vs. In-House Testing
This distinction is more important than most people realize. In-house testing means the same company selling you the peptide also performed the quality control testing. Third-party testing means an independent laboratory, with no financial interest in the outcome, performed the analysis.
Both have value. In-house testing is faster and cheaper, and reputable manufacturers have excellent internal QC. But third-party testing eliminates conflict of interest and provides the strongest form of independent verification.
Third-Party Testing
Independent lab performs analysis. No financial conflict of interest. Results are verifiable on the lab's server. Strongest form of quality assurance. Adds cost and time to the supply chain.
In-House Testing
Vendor or manufacturer tests their own product. Faster and less expensive. Quality depends on the company's integrity and equipment. Can be supplemented with periodic third-party audits.
The gold standard used by premium suppliers is a two-stage verification process: the manufacturer tests the raw peptide material, and then an independent third-party lab re-verifies the finished product. This combination provides both speed and independence.
Red Flags: How to Spot a Fake or Inadequate COA
Warning Signs to Watch For
Before purchasing from any supplier, request a sample COA for one of their products. If they will not provide one before you buy, move on. If the COA they provide triggers any of the red flags above, ask direct questions. A reputable supplier will have clear, confident answers. An evasive supplier is telling you something important through what they will not say.
Research Grade vs. GMP Grade: What is the Difference?
| Feature | Research Grade (RUO) | cGMP / Pharmaceutical Grade |
|---|---|---|
| Intended use | Research only, not for human use | Clinical trials, human therapeutics |
| Regulatory oversight | Minimal (varies by jurisdiction) | FDA, EMA, ICH Q7 compliance |
| Standard COA includes | HPLC purity, MS identity | All of the above plus AAA, water, solvents, endotoxin, sterility, bioburden, mass balance |
| Impurity profiling | Total impurities only | Specified + unspecified individual impurities |
| Third-party testing | Varies by supplier | Required at multiple stages |
| Batch documentation | COA only | Full batch records, deviation reports, environmental monitoring |
| Cost | Lower | Significantly higher |
The term "pharmaceutical grade" gets thrown around loosely in the peptide market. True pharmaceutical grade requires ICH Q7-level manufacturing documentation, validated analytical methods, full impurity characterization, and regulatory oversight at every step. If a vendor claims pharmaceutical grade but only provides a basic HPLC/MS COA, the claim does not match the documentation.
Your COA Evaluation Checklist
Use this every time you receive a new peptide. It takes five minutes and can save you from wasting money on a compromised product or, worse, putting an unverified compound into your research.
Before You Buy
When You Receive the Product
The Bottom Line
A COA is not a marketing document. It is a scientific instrument. Learning to read one properly gives you the ability to distinguish between a verified research compound and an expensive guess. In an unregulated market where social media hype drives purchasing decisions and the same white powder could be anything from a precisely synthesized peptide to a degraded impurity cocktail, the COA is your line of defense.
The three tests that matter most are mass spectrometry (identity), HPLC (purity), and net peptide content (dosing accuracy). Third-party testing from an independent lab provides the strongest form of verification. Red flags like missing batch numbers, absent MS data, recycled documentation, or unverifiable results should prompt you to either ask hard questions or find a different supplier.
Spend five minutes reading the COA every time you receive a new product. It is the single most valuable quality control habit you can build.
"Science depends on reproducibility. When a study uses a peptide without verified purity and identity, the results become impossible to replicate. Was the observed effect from the peptide, or from the 15% impurities in an untested product? The COA answers that question before you ever open the vial. Treat it accordingly."
Sources: AmbioPharm (cGMP COA specifications), Bachem (Quality Control of Amino Acids and Peptides), Verified Peptides (COA knowledge hub), Premier Bio Labs (How to Read a COA), Honest Peptide (Real vs Fake COA), BodySpec (Peptide Sciences quality guide), DN Lab Research (COA guide), USP General Chapter 1043, Pennington et al., Medicine in Drug Discovery (2021).
Important: Research-use-only (RUO) peptides are not approved for human or veterinary use. This article is for informational and educational purposes only. It does not constitute medical advice, an endorsement of any vendor, or a recommendation to use any peptide for any purpose. All analytical decisions should be made in consultation with qualified professionals.
Last updated: February 2026